Announcements Trials

Browse Landscape

Phase

Phase 2 26 Phase 3 10 Phase 1 2 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

OTHER 49 OTHER_GOV 1 NIH 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

Radiotherapy 10 Magnetic Resonance Spectroscopy 7 Early Intervention, Educational 7 Standard of Care 6 Interviews as Topic 6 Educational Status 6 Radiotherapy, Conformal 5 Practice Guidelines as Topic 5 Methods 5 Cyclophosphamide 5 Vincristine 4 Specimen Handling 4 Psychiatric Rehabilitation 4 Cisplatin 4 Brachytherapy 4 Biopsy 4 Surgical Procedures, Operative 3 Radiosurgery 3 Granulocyte Colony-Stimulating Factor 3 Fluorodeoxyglucose F18 3 Filgrastim 3 Etoposide 3 Dexamethasone 3 Counseling 3 Carboplatin 3 pegaspargase 2 motexafin gadolinium 2 etoposide phosphate 2 X-Rays 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × NETWORK × Bevacizumab × Clear all

NCT00911716 2019-08-01

TC Avastin. ICORG 08-10, V6

Cancer Trials Ireland

Phase NA Completed

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡